Modern Action logo
IssuesBillsBriefingNewsletterAbout
Donate
Donate
Modern Action

Navigation

Menu

01HomeFront page→02IssuesActive issue pages→03BillsLegislation index→04BriefingDaily context→05NewsletterWeekly Watchlist→06AboutMission and team→07DonateSupport the work→

Account

Sign In→Get Started→
Modern Action

Find the bills behind the news, understand what Congress can do, and contact your representatives with a specific message.

Platform

  • Contact Congress
  • Write to Congress
  • Browse Bills
  • Bill Explainers
  • Track Bills

Resources

  • Find My Representatives
  • Contact My Representatives
  • How to Contact Representatives
  • Does Contacting Congress Work?
  • Newsletter

Support

  • About
  • Contact Us
  • Press
  • Accessibility

Legal

  • Privacy Policy
  • Terms of Service
  • Cookie Policy
  • Accessibility

Stay informed about legislation

Get weekly updates on important bills and how to take action.

© 2026 Modern Action. All rights reserved.

Made with ❤️ for democracy
All systems operational

Contact Congress about H.R. 950: Saving Seniors Money on Prescriptions Act

PBMs that run Medicare drug benefits would have to report much more about prices, rebates, fees, and their own earnings. Medicare plans could audit them every year. The bill starts with plan years on or after January 1, 2028, but it does not directly cut what seniors pay at the pharmacy.

Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.

Saving Seniors Money on Prescriptions Act is a House bill in committee. The latest recorded action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Latest action on H.R. 950: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Who this affects: This bill mainly affects PBMs, Medicare drug plans, and people in Medicare drug coverage. PBMs would have the biggest new workload because they would need to track, explain, and turn over much more data. Medicare plan sponsors could gain more power to check PBM performance. People with Medicare could be affected later if plans use this information to change benefits, pharmacy networks, or contracts.

Why this matters: This bill matters because Medicare drug spending can be shaped by deals and fees that are hard to see from the outside. It would force more of that information into the open for Medicare plans and federal officials. That could make it easier to spot where money goes, where cheaper drugs are passed over, and whether PBMs follow their contracts. Still, the bill stops at transparency. Any direct savings for patients would depend on what plans, regulators, or Congress do next.

Key provisions in H.R. 950

  • This bill would cover all Medicare Part D drug plans and Medicare Advantage plans with drug coverage. It would start with plan years on or after January 1, 2028.
  • PBMs would have to use clear, consistent meanings for key pricing terms. That includes terms like generic drug, brand drug, specialty drug, rebate, and discount.
  • PBMs would have to send plan sponsors a report every year by July 1. The report would cover the last plan year and include drug-by-drug data on use, prices, rebates, discounts, and what patients paid out of pocket.
  • PBMs would have to show the full amount spent on drugs and the lower amount after rebates and fees. They would also have to show how much revenue the PBM and its related companies kept from each plan's prescription drug business.
  • PBMs that own or are tied to pharmacies would face extra reporting rules. They would have to compare total plan and patient costs at their own pharmacies versus other pharmacies and show how often their own pharmacies were used.

How Modern Action helps you take action on H.R. 950

You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.

Questions people ask about H.R. 950

What is H.R. 950?
PBMs that run Medicare drug benefits would have to report much more about prices, rebates, fees, and their own earnings. Medicare plans could audit them every year. The bill starts with plan years on or after January 1, 2028, but it does not directly cut what seniors pay at the pharmacy.
How do I support or oppose H.R. 950?
Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.
Who should I contact about H.R. 950?
Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.
Can Modern Action explain H.R. 950 before I act?
Yes. Modern Action gives you a plain-English summary, current status, and action context before you send anything.

Keep acting on Modern Action

More ways to act on this issue

Compare the broader issue and related bills without leaving Modern Action.

Related issues

  • Contact your reps on Medicare Drug Payment and Pharmacy AccessMedicare Part B or Part D drug payment rules tied to outpatient care, PBM compensation in Medicare, rebates, pharmacy network access, formulary oversight, pharmacy performance fees, and drug cost-sharing calculations.

Related bills

  • Take action on H.R. 2880: Protecting Patients Against PBM Abuses Act
  • Take action on S. 2973: Modernizing and Ensuring PBM Accountability Act
  • Take action on S. 882: Patients Before Middlemen Act
  • Take action on H.R. 4299: Protecting Patient Access to Cancer and Complex Therapies Act
  • Take action on H.R. 4317: PBM Reform Act of 2025
  • Take action on H.R. 4822: Health Care Price Transparency Act of 2023
  • Take action on S. 3345: PBM Price Transparency and Accountability Act